🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
307,02 USD
Máx. histórico
322,75
3 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-4,87%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-4,87%
Cierre anterior
322,75
Rango de hoy
306,17 – 324,95
Volumen hoy
265.433
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 32,35 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/02/2026 | 183,90 | 186,74 | 182,63 | 183,83 | +1,20% | 2,23% | 129.200 |
| 12/02/2026 | 188,21 | 191,47 | 180,24 | 181,65 | -2,32% | 5,97% | 271.200 |
| 11/02/2026 | 188,02 | 188,32 | 179,20 | 185,96 | -0,57% | 4,85% | 175.900 |
| 10/02/2026 | 186,96 | 187,88 | 182,65 | 187,02 | +0,05% | 2,80% | 253.700 |
| 09/02/2026 | 190,44 | 191,74 | 180,47 | 186,93 | -1,84% | 5,92% | 250.100 |
| 06/02/2026 | 194,61 | 197,00 | 189,17 | 190,44 | -0,65% | 4,02% | 272.800 |
| 05/02/2026 | 196,25 | 202,79 | 188,80 | 191,69 | -3,35% | 7,13% | 218.900 |
| 04/02/2026 | 200,32 | 201,99 | 196,07 | 198,33 | -0,26% | 2,96% | 117.500 |
| 03/02/2026 | 198,88 | 200,78 | 194,53 | 198,84 | +0,46% | 3,14% | 162.800 |
| 02/02/2026 | 192,18 | 198,18 | 191,50 | 197,93 | +3,03% | 3,48% | 152.500 |
| 30/01/2026 | 193,34 | 196,44 | 189,49 | 192,10 | -1,57% | 3,59% | 184.900 |
| 29/01/2026 | 190,21 | 195,41 | 189,30 | 195,17 | +2,60% | 3,21% | 186.500 |
| 28/01/2026 | 195,60 | 195,86 | 189,82 | 190,22 | -2,70% | 3,09% | 175.500 |
| 27/01/2026 | 197,97 | 200,74 | 194,93 | 195,49 | -1,38% | 2,93% | 154.500 |
| 26/01/2026 | 200,17 | 203,53 | 197,71 | 198,22 | -1,46% | 2,91% | 189.500 |
| 23/01/2026 | 203,87 | 205,87 | 197,92 | 201,15 | -1,31% | 3,90% | 198.900 |
| 22/01/2026 | 199,51 | 207,06 | 199,51 | 203,82 | +2,16% | 3,78% | 311.300 |
| 21/01/2026 | 197,82 | 202,40 | 194,97 | 199,51 | +1,50% | 3,76% | 196.700 |
| 20/01/2026 | 190,01 | 197,09 | 189,26 | 196,56 | +1,86% | 4,12% | 184.100 |
| 16/01/2026 | 195,01 | 196,05 | 188,13 | 192,97 | -1,59% | 4,06% | 219.800 |
| 15/01/2026 | 197,57 | 199,35 | 190,98 | 196,08 | -0,23% | 4,24% | 329.800 |
| 14/01/2026 | 188,38 | 197,49 | 186,26 | 196,54 | +4,11% | 5,96% | 285.800 |
| 13/01/2026 | 196,96 | 199,00 | 175,89 | 188,78 | -8,72% | 11,73% | 939.900 |
| 12/01/2026 | 207,82 | 210,27 | 205,25 | 206,81 | +0,08% | 2,42% | 291.000 |
| 09/01/2026 | 200,01 | 206,94 | 197,91 | 206,65 | +3,29% | 4,51% | 188.800 |
| 08/01/2026 | 200,24 | 204,86 | 197,04 | 200,07 | +0,06% | 3,91% | 118.000 |
| 07/01/2026 | 197,42 | 206,44 | 194,78 | 199,96 | +2,01% | 5,91% | 181.900 |
| 06/01/2026 | 192,02 | 197,03 | 189,88 | 196,02 | +2,08% | 3,72% | 144.500 |
| 05/01/2026 | 189,43 | 193,00 | 187,08 | 192,03 | +1,01% | 3,13% | 125.500 |
| 02/01/2026 | 188,60 | 192,48 | 186,48 | 190,11 | +0,55% | 3,18% | 205.800 |